ĐIỀU TRỊ THIẾU MÁU THIẾU SẮT BẰNG BỔ SUNG SẮT ĐƯỜNG TĨNH MẠCH TRÊN BỆNH NHÂN THẬN NHÂN TẠO CHU KÌ

Abstract

Objectives: Evaluate the results of treatment of iron deficiency anemia with intravenous iron supplementation in hemodialysis patients. Subject and methods: Using a prospective descriptive research method to compare results before and after 1 and 3 months of intravenous iron supplementation in patients with indications for intravenous iron infusion (TSAT < 30% and ferritin < 500ng/ml). Result: Iron concentration, serum ferritin, TSAT all increased significantly after iron infusion 1 month and 3 months. Hemoglobin concentration at time T0 was 94.26 ± 13.25 g/l, increasing to 105.32 ± 15.76 g/l after only 1 month of iron infusion. Approximately 50% of patients have an increase in hemoglobin concentration rate of ≥ 10 g/l/month. The proportion of patients with hemoglobin concentration >= 110 g/l accounted for 42.1% after 1 month and remained at 34.2% after 3 months of intravenous iron infusion. Only 2 patients had headaches, 1 patient had transient nausea and no patient had serious side effects. Conclusion: Intravenous iron supplementation for hemodialysis patients with iron deficiency has significantly improved anemia. At the same time, it still ensures safety and has less side effects.